Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report.
Takashi KatoYusuke KunimotoManabu KitagawaYuichiro AsaiTomoko KimyoHiromasa NakataMamoru TakahashiHirofumi ChibaHiroki TakahashiAtsushi MiyamotoMasahide FukudoPublished in: Journal of pharmaceutical health care and sciences (2023)
Close monitoring of INR and adjustment of warfarin dosage are needed during treatment with alectinib, crizotinib, or ceritinib in patients who receive warfarin with concurrent use of bucolome.